Cantargia AB logo

CANTA - Cantargia AB Share Price

SEK15.5 -0.2  -1.2%

Last Trade - 5:00pm

Sector
Healthcare
Size
Small Cap
Market Cap £94.1m
Enterprise Value £76.1m
Revenue £n/a
Position in Universe 729th / 1467
Bullish
Bearish
Unlock CANTA Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CANTA Revenue Unlock CANTA Revenue

Net Income

CANTA Net Income Unlock CANTA Revenue

Normalised EPS

CANTA Normalised EPS Unlock CANTA Revenue

PE Ratio Range

CANTA PE Ratio Range Unlock CANTA Revenue

Dividend Yield Range

CANTA Dividend Yield Range Unlock CANTA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CANTA EPS Forecasts Unlock CANTA Revenue
Profile Summary

Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Cantargia AB uses the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since March 17, 2015
No. of Shareholders: n/a
No. of Employees: 8
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 72,804,392
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CANTA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CANTA
Upcoming Events for CANTA
Wednesday 13th November, 2019 Estimate
Q3 2019 Cantargia AB Earnings Release
Tuesday 25th February, 2020 Estimate
Q4 2019 Cantargia AB Earnings Release
Similar to CANTA
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.